◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

LIFECORE BIOMEDICAL, INC. DE

CIK: 1005286 SIC: 2834
$135.27M
Revenue
$-32.48M
Net Income
31.57%
Gross Margin
-6.45%
Op. Margin
$-26.21M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 12 of 12 annual reports available (2012 - 2025)
Breakdown TTM
(Sep 30, 2025)
FY 2025
(May 31, 2025)
FY 2024
(May 31, 2024)
FY 2023
(May 31, 2023)
FY 2021
(May 31, 2021)
FY 2020
(May 31, 2020)
FY 2019
(May 31, 2019)
FY 2018
(May 31, 2018)
FY 2016
(May 31, 2016)
FY 2015
(May 31, 2015)
FY 2014
(May 31, 2014)
FY 2013
(May 31, 2013)
FY 2012
(May 31, 2012)
+ Total Revenue $135.27M $128.87M $128.26M $103.27M $544.16M $590.37M $557.56M $524.23M $476.92M $539.26M $476.81M $441.71M $317.55M
Revenue Growth % 5.0% 0.5% 24.2% -81.0% -7.8% 5.9% 6.4% 9.9% -11.6% 13.1% 7.9% 39.1% nan%
Cost of Revenue $92.57M $88.57M $86.41M $75.28M $462.69M $515.38M $476.56M $445.89M $410.14M $473.85M $414.25M $378.95M $265.41M
+ Gross Profit $42.70M $40.30M $41.85M $27.98M $81.47M $74.99M $81.00M $78.34M $70.96M $65.41M $62.56M $62.76M $52.14M
Gross Margin % 31.6% 31.3% 32.6% 27.1% 15.0% 12.7% 14.5% 14.9% 14.9% 12.1% 13.1% 14.2% 16.4%
Operating Expenses - - $50.69M $49.78M $94.97M $113.53M $75.53M $64.75M $90.74M $46.95M $42.37M $37.89M $37.56M
Research & Development $8.04M $8.26M $8.57M $8.74M $10.22M $11.10M $11.47M $12.80M $7.23M $6.99M $7.20M $9.29M $9.62M
Selling General & Admin $39.09M $44.05M $40.46M $38.97M $65.36M $72.19M $62.06M $51.95M $49.52M $39.96M $35.17M $32.53M $26.52M
+ Operating Income $-8.73M $-17.25M $-8.84M $-21.80M $-13.50M $-38.54M $5.47M $13.59M $-19.79M $18.46M $20.19M $24.87M $14.58M
Operating Margin % -6.5% -13.4% -6.9% -21.1% -2.5% -6.5% 1.0% 2.6% -4.1% 3.4% 4.2% 5.6% 4.6%
Interest Expense - - $2.73M $17.65M $8.93M $10.13M $5.61M $2.29M $1.99M $1.83M $1.65M $2.01M $929.00K
Interest Income - - - $68.00K $48.00K $103.00K $145.00K $211.00K $71.00K $315.00K $260.00K $179.00K $180.00K
Other Income/Expense $310.00K $-3.00K $-3.05M $-1.16M $-11.69M $-4.39M $1.60M $2.90M $1.20M $3.11M $10.00M $8.10M $5.33M
Income Before Tax $-32.08M $-38.67M $9.51M $-63.93M $-40.47M $-51.31M $3.64M $16.40M $-19.69M - - $32.26M $20.28M
Income Tax Expense $401.00K $43.00K $183.00K $308.00K $-7.80M $-13.12M $1.52M $-9.36M $-7.70M - - $9.45M $-7.18M
+ Net Income $-32.48M $-38.72M $12.01M $-99.56M $-32.66M $-38.19M $411.00K $24.83M $-11.64M $13.72M $19.34M $22.59M $12.70M
Net Margin % -24.0% -30.0% 9.4% -96.4% -6.0% -6.5% 0.1% 4.7% -2.4% 2.5% 4.1% 5.1% 4.0%
Basic EPS -1.04 -1.27 0.40 -3.32 -1.12 -1.31 0.01 0.90 -0.43 0.50 0.72 0.87 0.49
Diluted EPS -1.04 -1.27 0.32 -3.32 -1.12 -1.31 0.01 0.89 -0.43 0.50 0.71 0.85 0.49
Basic Shares Outstanding 37.4M 34.8M 30.5M 30.0M 29.3M 29.2M 28.4M 27.5M 27.0M 27K 26.6M 25.8M 26K
Diluted Shares Outstanding 37.4M 34.8M 36.7M 30.0M 29.3M 29.2M 28.6M 27.9M 27.0M 27K 27.1M 26.6M 26K
Breakdown FY 2025
(May 31, 2025)
FY 2024
(May 31, 2024)
FY 2023
(May 31, 2023)
FY 2021
(May 31, 2021)
FY 2020
(May 31, 2020)
FY 2019
(May 31, 2019)
FY 2018
(May 31, 2018)
FY 2016
(May 31, 2016)
FY 2015
(May 31, 2015)
FY 2014
(May 31, 2014)
FY 2013
(May 31, 2013)
FY 2012
(May 31, 2012)
Cash & Cash Equivalents $8.27M $8.46M $19.09M $1.29M $360.00K $1.08M $2.90M $9.89M $14.13M $14.24M $13.72M $22.18M
Short-term Investments - - - - - - - - - - $1.54M -
Accounts Receivable - $31.15M $29.02M $70.01M $76.21M $69.56M $53.88M $46.41M $46.17M $44.42M $36.07M $31.95M
Inventory $32.29M $39.98M $40.84M $69.66M $66.31M $54.13M $31.82M $25.54M $25.03M $24.73M $24.11M $22.01M
Other Current Assets $1.45M $1.44M $4.92M $7.35M $14.23M $8.26M $7.96M $4.64M $5.31M $3.17M $2.86M $2.58M
Total Current Assets $85.68M $81.03M $93.88M $148.32M $157.11M $133.04M $97.06M $86.48M $93.20M $90.93M $85.66M $81.16M
Property Plant & Equipment $129.01M $148.60M $134.39M $179.56M $192.34M $200.03M $159.62M $120.88M $84.47M $74.14M $65.81M $63.49M
Goodwill $13.88M $13.88M $13.88M $69.39M $69.39M $76.74M $54.51M $49.62M $49.62M $49.62M $49.62M $49.62M
Intangible Assets $4.20M $4.20M $4.20M - - - - - - - - -
Other Non-current Assets $6.58M $3.81M $2.92M $3.61M $2.16M $2.93M $5.16M $2.40M $1.42M $1.39M $1.42M $2.14M
Total Assets $239.34M $253.96M $253.54M $502.92M $541.31M $519.09M $404.70M $343.47M $346.46M $313.62M $290.94M $277.69M
Accounts Payable $8.22M $16.33M $22.10M $47.57M $51.65M $53.97M $34.67M $30.90M $34.77M $31.98M $31.47M $22.64M
Accrued Liabilities $21.96M $22.54M - - - - - - - - - -
Deferred Revenue - - $4.05M $1.13M $352.00K $499.00K $2.62M $832.00K $843.00K $1.25M $1.25M $162.00K
Other Current Liabilities - - - - - $1.74M $5.28M $1.74M $1.69M - - -
Total Current Liabilities $30.18M $38.87M $39.29M $101.89M $164.39M $137.09M $88.38M $56.52M $56.16M $48.39M $50.75M $66.68M
Long-term Debt - $100.82M $84.26M $164.90M $101.36M $87.19M $37.36M $46.61M $34.17M $28.32M $34.37M $40.30M
Deferred Tax Liabilities - $543.00K $380.00K $6.14M $13.59M $19.39M - - - - - -
Other Non-current Liabilities $9.74M $5.09M $3.11M $3.60M $4.55M $1.74M - - $1.69M $2.02M $1.35M $1.11M
Total Liabilities $191.91M $200.06M $218.46M $300.14M $310.27M $248.95M $152.14M $131.12M $126.36M $108.86M $110.53M $126.13M
Common Stock $37.00K $30.00K $30.00K $29.00K $29.00K $29.00K $28.00K $27.00K $27.00K $27.00K $26.00K $26.00K
Retained Earnings $-205.24M $-166.52M $-178.54M $38.58M $71.25M $109.71M $109.30M $73.46M $85.10M $71.55M $52.41M $29.82M
Total Stockholders Equity $1.34M $11.31M $-4.23M $202.78M $231.04M $270.14M $252.56M $210.73M $218.43M $203.07M $178.69M $149.74M
Total Liabilities & Equity $239.34M $253.96M $253.54M $502.92M $541.31M $519.09M $404.70M $343.47M $346.46M $313.62M $290.94M $277.69M
Breakdown TTM
(Sep 30, 2025)
FY 2025
(May 31, 2025)
FY 2024
(May 31, 2024)
FY 2023
(May 31, 2023)
FY 2021
(May 31, 2021)
FY 2020
(May 31, 2020)
FY 2019
(May 31, 2019)
FY 2018
(May 31, 2018)
FY 2016
(May 31, 2016)
FY 2015
(May 31, 2015)
FY 2014
(May 31, 2014)
FY 2013
(May 31, 2013)
FY 2012
(May 31, 2012)
Net Income $-55.28M $-38.72M $12.01M $-99.56M $-32.66M $-38.19M $411.00K $24.83M $-11.64M $13.72M $19.34M $22.59M $12.70M
Depreciation & Amortization $14.04M $8.03M $8.86M $13.29M $19.87M $18.84M $15.23M $12.41M $9.39M $7.09M $7.11M $7.29M $5.62M
Stock-based Compensation $18.34M $10.16M $6.20M $3.61M $3.36M $2.42M $3.56M $4.40M $3.46M $1.58M $1.36M $1.70M $1.87M
Deferred Income Tax - - - - - - - - $-9.79M $4.15M $5.61M $6.51M $3.28M
Change in Receivables - $2.26M $3.26M $-10.82M $-5.78M $6.64M $8.86M $7.31M $-73.00K $1.75M $7.99M $4.12M $3.25M
Change in Inventory $-10.42M $-7.69M $-862.00K $14.81M $3.35M $12.18M $10.93M $6.53M $508.00K $292.00K $622.00K $2.10M $-441.00K
Change in Payables $1.38M $-1.67M $-6.68M $16.04M $-5.98M $-1.25M $19.12M $4.96M $-4.11M $2.78M $-50.00K $8.83M $-544.00K
Operating Cash Flow $-5.20M $-206.00K $-217.00K $-17.44M $15.02M $-17.04M $16.02M $19.78M $20.76M - - $21.23M $22.18M
Capital Expenditure $21.01M $13.41M $18.39M - $23.77M $26.69M $44.73M $33.59M $40.87M $17.51M $14.89M $8.88M $5.37M
Acquisitions - - - - - - $59.87M - - - - - $66.83M
Purchases of Investments - - - - - - - - - $18.00M - - $30.72M
Sales of Investments - - - - - - - - - - - - $31.10M
Investing Cash Flow $-14.01M $-6.42M $-17.92M $-4.81M $-10.86M $-23.89M $-96.80M $-35.59M $-40.42M - - $-10.42M $-44.07M
Debt Repayment - - - $123.69M $114.13M $11.12M $5.09M $5.08M $14.65M $6.87M $5.93M $7.01M $4.33M
Stock Issued $47.69M $23.85M - $4.82M - $30.00K $327.00K $56.00K $322.00K $122.00K $2.30M $3.42M $61.00K
Stock Repurchased - - - - - - - - - - - - $5.01M
Financing Cash Flow $18.64M $6.42M $7.51M $39.70M $-3.42M $40.02M $79.03M $13.29M $15.42M - - $-19.27M $35.93M
Net Change in Cash $-567.00K $-197.00K $-10.63M $17.45M $742.00K $-912.00K $-1.75M $-2.52M $-4.23M $-116.00K $525.00K $-8.46M $14.04M
SEC Filing Format - Data shown as it appears in the Q1 2026 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025
Current Prior Year
Total Revenue $31.11M $24.70M
Cost of Revenue $23.32M $19.32M
Gross Profit $7.79M $5.39M
Research & Development $1.96M $2.19M
Selling General & Admin $8.89M $14.79M
Operating Income $-3.07M $-11.58M
Interest Income $58.00K $15.00K
Other Income/Expense $110.00K $-203.00K
Income Before Tax $-9.66M $-16.25M
Income Tax Expense $333.00K $-25.00K
Net Income $-9.99M $-16.23M
Basic EPS -0.29 -0.53
Diluted EPS -0.29 -0.53
Basic Shares Outstanding $37.40M $30.86M
Diluted Shares Outstanding $37.40M $30.86M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 May 31, 2025
Cash & Cash Equivalents $18.86M $8.27M
Inventory $33.80M $32.29M
Other Current Assets $2.14M $1.45M
Total Current Assets $83.93M $85.68M
Property Plant & Equipment $128.57M $129.01M
Goodwill $13.88M $13.88M
Intangible Assets $4.20M $4.20M
Other Non-current Assets $4.62M $6.58M
Total Assets $235.20M $239.34M
Accounts Payable $10.12M $8.22M
Accrued Liabilities $19.84M $21.96M
Total Current Liabilities $29.96M $30.18M
Other Non-current Liabilities $7.96M $9.74M
Total Liabilities $198.42M $191.91M
Common Stock $37.00K $37.00K
Retained Earnings $-218.09M $-205.24M
Total Stockholders Equity $-10.54M $1.34M
Total Liabilities & Equity $235.20M $239.34M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025
Current Prior Year
Net Income $-9.99M $-16.23M
Depreciation & Amortization $1.98M $1.99M
Stock-based Compensation $2.39M $2.42M
Change in Receivables $4.58M $-6.08M
Change in Inventory $-1.97M $1.66M
Change in Payables $2.26M $3.63M
Operating Cash Flow $1.76M $-613.00K
Capital Expenditure $1.74M $3.42M
Investing Cash Flow $-1.74M $-3.42M
Stock Issued - $1.00K
Financing Cash Flow $-1.39M $1.09M
Net Change in Cash $-1.36M $-2.94M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...